We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$29.4B
AUM Growth
-$873M
Cap. Flow
+$534M
Cap. Flow %
1.81%
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$244M
2
ENPH icon
Enphase Energy
ENPH
+$229M
3
GSK icon
GSK
GSK
+$223M
4
ACN icon
Accenture
ACN
+$209M
5
C icon
Citigroup
C
+$209M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$294M
2
AMZN icon
Amazon
AMZN
+$272M
3
PYPL icon
PayPal
PYPL
+$271M
4
BAC icon
Bank of America
BAC
+$225M
5
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
+$212M

Sector Composition

Rank Sector Weight
1 Technology 21.52%
2 Healthcare 13.7%
3 Financials 9.76%
4 Industrials 8.72%
5 Consumer Discretionary 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPUH
2151
DELISTED
Compute Health Acquisition Corp.
CPUH
$148K ﹤0.01%
+15,000
New +$148K
MDH
2152
DELISTED
MDH Acquisition Corp.
MDH
$148K ﹤0.01%
+15,000
New +$148K
LITS
2153
Lite Strategy Inc
LITS
$35M
$147K ﹤0.01%
18,951
+6,353
+50% +$65.6K
SCPL
2154
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$147K ﹤0.01%
12,500
-154,667
-93% -$1.93M
BNBX
2155
DELISTED
BNB PLUS CORP
BNBX
$146K ﹤0.01%
+9
New +$307K
LPCN icon
2156
Lipocine
LPCN
$17M
$146K ﹤0.01%
19,127
-7,854
-29% -$87.7K
ITI
2157
DELISTED
Iteris, Inc.
ITI
$146K ﹤0.01%
49,059
-65,036
-57% -$194K
FUV
2158
DELISTED
Arcimoto, Inc. Common Stock
FUV
$146K ﹤0.01%
5,303
+4,788
+930% +$239K
NPKI
2159
NPK International
NPKI
$1.12B
$145K ﹤0.01%
57,722
-199,275
-78% -$586K
ATXI
2160
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$145K ﹤0.01%
+191
New +$61.2K
SLRC icon
2161
SLR Investment Corp
SLRC
$693M
$143K ﹤0.01%
11,616
-101,480
-90% -$1.49M
VRCA icon
2162
Verrica Pharmaceuticals
VRCA
$83.7M
$143K ﹤0.01%
4,889
-538
-10% -$18.4K
HCIC
2163
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$141K ﹤0.01%
+14,335
New +$141K
OPTN
2164
DELISTED
OptiNose
OPTN
$140K ﹤0.01%
+2,553
New +$140K
REAL icon
2165
The RealReal
REAL
$1.37B
$140K ﹤0.01%
93,352
-1,638,580
-95% -$3.96M
EPSN icon
2166
Epsilon Energy
EPSN
$170M
$139K ﹤0.01%
+21,936
New +$143K
EARN
2167
Ellington Residential Mortgage REIT
EARN
$168M
$138K ﹤0.01%
+22,332
New +$178K
ALGS icon
2168
Aligos Therapeutics
ALGS
$43.3M
$137K ﹤0.01%
4,977
-2,839
-36% -$94.3K
OSUR icon
2169
OraSure Technologies
OSUR
$263M
$136K ﹤0.01%
35,872
-312,917
-90% -$1.13M
FDMT icon
2170
4D Molecular Therapeutics
FDMT
$850M
$132K ﹤0.01%
16,449
-29,546
-64% -$268K
BRLT icon
2171
Brilliant Earth
BRLT
$22.5M
$131K ﹤0.01%
+22,864
New +$148K
QMCO icon
2172
Quantum Corp
QMCO
$850M
$130K ﹤0.01%
6,026
-4,451
-42% -$143K
VTGN icon
2173
VistaGen Therapeutics
VTGN
$10.8M
$129K ﹤0.01%
28,203
+26,425
+1,486% +$262K
METC icon
2174
Ramaco Resources Class A
METC
$788M
$127K ﹤0.01%
14,217
-243,276
-94% -$2.51M
CBIO
2175
Crescent Biopharma
CBIO
$630M
$126K ﹤0.01%
2,283
-940
-29% -$67.6K
85 86
87
88 89

Similar funds

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

John Overdeck's Q3 2022 Portfolio in Review

As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
  • John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
  • John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
  • John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
  • John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
  • John Overdeck opened 582 new positions and closed 600 in Q3 2022.
  • John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.